Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial

INTRODUCTION: Osteopontin (OPN) is a malignancy-associated glycoprotein that contributes functionally to tumor aggressiveness. In metastatic breast cancer, we previously demonstrated that elevated OPN in primary tumor and blood was associated with poor prognosis. METHODS: We measured OPN in plasma b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bramwell, Vivien HC, Tuck, Alan B, Chapman, Judith-Anne W, Anborgh, Pieter H, Postenka, Carl O, Al-Katib, Waleed, Shepherd, Lois E, Han, Lei, Wilson, Carolyn F, Pritchard, Kathleen I, Pollak, Michael N, Chambers, Ann F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978736/
https://www.ncbi.nlm.nih.gov/pubmed/24451146
http://dx.doi.org/10.1186/bcr3600

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978736/
https://www.ncbi.nlm.nih.gov/pubmed/24451146
http://dx.doi.org/10.1186/bcr3600

Ejemplares similares